By expenditures
| Name | Title | Type |
|---|---|---|
| Devlyn Brooks | CEO | Auditee |
| Robben Luhning | Chief Financial Officer | Auditee |
| Jeremy Ulmer | Principal | Auditee |
| Reggie Macmaster | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 363689 | 2023 | 2025-08-05 | Brady Martz & Associates PC | $4.04M |
| 298678 | 2022 | 2024-03-27 | Eide Bailly | $1.38M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 363689 | 2023 | 2025-08-05 | 1148979 | 2023-011 | Material Weakness | - | L |
| 363689 | 2023 | 2025-08-05 | 1148978 | 2023-011 | Material Weakness | - | L |
| 363689 | 2023 | 2025-08-05 | 1148977 | 2023-011 | Material Weakness | - | L |
| 363689 | 2023 | 2025-08-05 | 1148976 | 2023-010 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 1148975 | 2023-010 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 1148974 | 2023-010 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 1148973 | 2023-009 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 1148972 | 2023-009 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 1148971 | 2023-009 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 1148970 | 2023-008 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 1148969 | 2023-008 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 1148968 | 2023-008 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 1148967 | 2023-007 | Significant Deficiency | Yes | AB |
| 363689 | 2023 | 2025-08-05 | 1148966 | 2023-007 | Significant Deficiency | Yes | AB |
| 363689 | 2023 | 2025-08-05 | 1148965 | 2023-007 | Significant Deficiency | Yes | AB |
| 363689 | 2023 | 2025-08-05 | 1148964 | 2023-006 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 1148963 | 2023-006 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 1148962 | 2023-006 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 572537 | 2023-011 | Material Weakness | - | L |
| 363689 | 2023 | 2025-08-05 | 572536 | 2023-011 | Material Weakness | - | L |
| 363689 | 2023 | 2025-08-05 | 572535 | 2023-011 | Material Weakness | - | L |
| 363689 | 2023 | 2025-08-05 | 572534 | 2023-010 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 572533 | 2023-010 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 572532 | 2023-010 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 572531 | 2023-009 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 572530 | 2023-009 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 572529 | 2023-009 | Material Weakness | Yes | I |
| 363689 | 2023 | 2025-08-05 | 572528 | 2023-008 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 572527 | 2023-008 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 572526 | 2023-008 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 572525 | 2023-007 | Significant Deficiency | Yes | AB |
| 363689 | 2023 | 2025-08-05 | 572524 | 2023-007 | Significant Deficiency | Yes | AB |
| 363689 | 2023 | 2025-08-05 | 572523 | 2023-007 | Significant Deficiency | Yes | AB |
| 363689 | 2023 | 2025-08-05 | 572522 | 2023-006 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 572521 | 2023-006 | Material Weakness | - | AB |
| 363689 | 2023 | 2025-08-05 | 572520 | 2023-006 | Material Weakness | - | AB |
| 298678 | 2022 | 2024-03-27 | 962725 | 2022-008 | Material Weakness | - | I |
| 298678 | 2022 | 2024-03-27 | 962724 | 2022-007 | Significant Deficiency | Yes | I |
| 298678 | 2022 | 2024-03-27 | 962723 | 2022-006 | Significant Deficiency | - | AB |
| 298678 | 2022 | 2024-03-27 | 962722 | 2022-005 | Material Weakness | Yes | AB |
| 298678 | 2022 | 2024-03-27 | 962721 | 2022-008 | Material Weakness | - | I |
| 298678 | 2022 | 2024-03-27 | 962720 | 2022-007 | Significant Deficiency | Yes | I |
| 298678 | 2022 | 2024-03-27 | 962719 | 2022-006 | Significant Deficiency | - | AB |
| 298678 | 2022 | 2024-03-27 | 962718 | 2022-005 | Material Weakness | Yes | AB |
| 298678 | 2022 | 2024-03-27 | 962717 | 2022-008 | Material Weakness | - | I |
| 298678 | 2022 | 2024-03-27 | 962716 | 2022-007 | Significant Deficiency | Yes | I |
| 298678 | 2022 | 2024-03-27 | 962715 | 2022-006 | Significant Deficiency | - | AB |
| 298678 | 2022 | 2024-03-27 | 962714 | 2022-005 | Material Weakness | Yes | AB |
| 298678 | 2022 | 2024-03-27 | 962713 | 2022-008 | Material Weakness | - | I |
| 298678 | 2022 | 2024-03-27 | 962712 | 2022-007 | Significant Deficiency | Yes | I |
| 298678 | 2022 | 2024-03-27 | 962711 | 2022-006 | Significant Deficiency | - | AB |
| 298678 | 2022 | 2024-03-27 | 962710 | 2022-005 | Material Weakness | Yes | AB |
| 298678 | 2022 | 2024-03-27 | 386283 | 2022-008 | Material Weakness | - | I |
| 298678 | 2022 | 2024-03-27 | 386282 | 2022-007 | Significant Deficiency | Yes | I |
| 298678 | 2022 | 2024-03-27 | 386281 | 2022-006 | Significant Deficiency | - | AB |
| 298678 | 2022 | 2024-03-27 | 386280 | 2022-005 | Material Weakness | Yes | AB |
| 298678 | 2022 | 2024-03-27 | 386279 | 2022-008 | Material Weakness | - | I |
| 298678 | 2022 | 2024-03-27 | 386278 | 2022-007 | Significant Deficiency | Yes | I |
| 298678 | 2022 | 2024-03-27 | 386277 | 2022-006 | Significant Deficiency | - | AB |
| 298678 | 2022 | 2024-03-27 | 386276 | 2022-005 | Material Weakness | Yes | AB |
| 298678 | 2022 | 2024-03-27 | 386275 | 2022-008 | Material Weakness | - | I |
| 298678 | 2022 | 2024-03-27 | 386274 | 2022-007 | Significant Deficiency | Yes | I |
| 298678 | 2022 | 2024-03-27 | 386273 | 2022-006 | Significant Deficiency | - | AB |
| 298678 | 2022 | 2024-03-27 | 386272 | 2022-005 | Material Weakness | Yes | AB |
| 298678 | 2022 | 2024-03-27 | 386271 | 2022-008 | Material Weakness | - | I |
| 298678 | 2022 | 2024-03-27 | 386270 | 2022-007 | Significant Deficiency | Yes | I |
| 298678 | 2022 | 2024-03-27 | 386269 | 2022-006 | Significant Deficiency | - | AB |
| 298678 | 2022 | 2024-03-27 | 386268 | 2022-005 | Material Weakness | Yes | AB |